Correct Want2Know
Beckman Coulter remains a ‘major player’
As I have previously posted I think that the Troponin test is one of the largest that can benefit from MixnGo - Not just from sensitivity but because of the market size of the Troponin test - greatest savings could be in labour and cost savings on antibody for the tests.
Beckman Coulter has had problems with FDA for some time but it seems since Danaher acquired them they are cleaning up the ship.
The first progress I saw was at the start of the year with FDA approval for Beckman Coulters AU5800 Chemistry Systems
Beckman Coulters AU5800 Chemistry Systems Receive FDA Clearance
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
0.001(8.33%) |
Mkt cap ! $35.16M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.5¢ | 1.2¢ | $134.6K | 10.18M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 1707865 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 97477 | 1 |
View Market Depth
| Last trade - 15.59pm 18/07/2025 (20 minute delay) ? |
| ADO (ASX) Chart |